April 2021

The National Institute of Immunology, New Delhi, is a leading research Institute in India with a long-standing reputation for scientific excellence. The institute is equipped with state-of-the-art infrastructure for pursuing research in immunology and allied sciences. The Institute also imparts vigorous long-term research training leading to a Ph.D degree.

Post : Research Associate (One position only)

Dr. Ram Manohar Lohia College of Pharmacy, was established in 2017 with a view to impart the best in pharmacy education. Since inception, through its commitment to Excellence and to raise its standard of education, it has acquired a name for itself. The institute is committed to impart the highest quality of education and exposure to help develop the next generation of Pharmacy leaders with global outlook and capability of adapting to changing requirements.

ICHAPPS allows you to get access to all the healthcare services and pharmaceutical details in just a few clicks. Consulting a doctor, getting a diagnostic test done, searching for pharmaceutical services like drug agencies, medical equipment and more, is now at your finger tips. Even for professionals and investors, we offer facilitation offerings to make the experience less complicated and more visible by providing the complete information to meet their needs, objectives and business goals.

Hamilton, ON (April 6, 2021) - If you are one of the millions of people worldwide suffering from allergies, you may take an antihistamine pill to ward off hives, sneezing and watery eyes. But you may be taking your medications incorrectly, says Derek Chu, a McMaster University allergy expert and clinical scholar.

The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease and hospitalisation. This interim safety and efficacy analysis was based on 32,449 participants accruing 141 symptomatic cases of COVID-19. The trial had a 2:1 randomisation of vaccine to placebo. Vaccine efficacy was consistent across ethnicity and age. Notably, in participants aged 65 years and over, vaccine efficacy was 80%.

Ionis Pharmaceuticals, Inc announced the initiation of a Phase 3 clinical trial of ION363 in patients with amyotrophic lateral sclerosis (ALS) with mutations in the fused in sarcoma gene (FUS). Patients with a mutation in the FUS gene develop a rare form of ALS, referred to as FUS-ALS, which is the most common cause of juvenile-onset ALS. There is substantial evidence that mutations in the FUS gene are responsible for a toxic gain of function that can lead to rapid, progressive loss of motor neurons in patients with FUS-ALS.

People suffering from Human Immunodeficiency Virus (HIV) infection can now hope to have a better quality of life with researchers at the Bengaluru-based Indian Institute of Science (IISc) developing a nano alternative to a natural enzyme that is used to block reactivation and replication of the virus in the host’s immune cells.

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Clinical Data Manager

Indian Institute of Chemical Technology (CSIR-IICT) is one of the oldest National Laboratories under the Council of Scientific & Industrial Research (CSIR). It started as the Central Laboratories for Scientific & Industrial Research (CLSIR) by the then princely State of Hyderabad in 1944. CSIR-IICT during its seventy year journey has made its mark as a dynamic, innovative and result oriented R&D organization. The clientele spans all comers of the globe. In India it is the reliable destination of chemical and biotech industries.